Phospholipid-Derived Mediators and Insulin Secretion

$413,804R37FY2003DKNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 33080873 Paper 30408523 Paper 25409104 Paper 25004092 Paper 24919816 Paper 24648512 Paper 24482376 Paper 23411472 Paper 23307809 Paper 23213352 Paper 22863804 Paper 22637477 Paper 22582025 Paper 22349267 Paper 22282097 Paper 22194610 Paper 22110477 Paper 22057271 Paper 21984569 Paper 21972013 Paper 21839170 Paper 21555485 Paper 21321118 Paper 21300801 Paper 21228317 Paper 21191104 Paper 21029305 Paper 20946862 Paper 20732873 Paper 20692852 Paper 20686114 Paper 20530749 Paper 20521843 Paper 20463052 Paper 20382858 Paper 20179248 Paper 20171120 Paper 20132906 Paper 20083151 Paper 19646743 Paper 19269264 Paper 19131280 Paper 19053227 Paper 18937505 Paper 18936091 Paper 18771936 Paper 18692406 Paper 18562612 Paper 18349124 Paper 18202189 Paper 17913512 Paper 17895289 Paper 17873277 Paper 17720531 Paper 17685585 Paper 17627946 Paper 17627842 Paper 17613534 Paper 17303435 Paper 17197450 Paper 17185615 Paper 17141526 Paper 17141525 Paper 16750386 Paper 16732058 Paper 16700550 Paper 16442306 Paper 16411783 Paper 16286468 Paper 16023863 Paper 15946940 Paper 15792718 Paper 15589755 Paper 15576376 Paper 15573142 Paper 15252026 Paper 15047058 Paper 14749286 Paper 14749285 Paper 14744135 Paper 14698549 Paper 14636061 Paper 12898655 Paper 12717757 Paper 12686482 Paper 12056568 Paper 12019979 Paper 11923099 Paper 11882502 Paper 11521967 Paper 11470087 Paper 11278673 Paper 11142362 Paper 11073262 Paper 11014451 Paper 10984107 Paper 10976887 Paper 10800048 Paper 10790848 Paper 10760474

Abstract

DESCRIPTION (provided by applicant): Our hypothesis in the previous project period was that a pancreatic islet Ca2+ -independent phospholipase A2 (iPLA2B) is activated upon stimulation with secretagogues and that its products participate in B-cell signaling. We have now cloned iPLA2B from islet mRNA and determined the human iPLA2 gene structure and chromosomal location. Recombinant iPLA2B is inhibited by a bromoenol lactone (BEL) suicide substrate that also suppresses glucose-induced insulin secretion, and iPLA2B overexpression. amplifies insulinoma cell secretion and proliferation. We have also found that arachidonate-containing plasmalogens, which participate in membrane fusion and exocytosis, are abundant in B-cells, and these ether lipids are produced from peroxisome-derived intermediates. An iPLA2gamma isozyme targeted to peroxisomes is also expressed in islets and may participate in regulating complex lipid synthesis. Peroxisomal dysregulation could contribute to pathologic tissue lipid accumulation in diabetes. The recent success of human islet transplantation and the limited availability of donor organs highlights the need to identify genes and their products that affect B-cell secretion and survival to facilitate construction of engineered B-cell lines that might serve as an alternate source of transplantable B-cells. In the coming project period, we propose to further characterize roles of iPLA2 isozymes, complex lipids, and peroxisomes in B-cell function and to develop genetically modified mice with altered iPLA2B expression for in vivo studies. Aim 1 is to characterize secretion, proliferation, and other responses of insulinoma cells and islets in which iPLA2B expression is manipulated by molecular biologic means. Aim 2 is to characterize roles of complex lipids in B-cell function and of iPLA2 isozymes and peroxisomes in lipid formation. Aim 3 is to characterize regulatory post-translational modifications of the iPLA2B protein. Aim 4 is to conduct cell biologic studies of iPLA2B translocation among cellular compartments and interactions with other proteins. Aim 5 is to develop genetically modified mice with altered iPLA2B expression for in vivo studies. We have prepared mouse embryonic stem cells in which an iPLA2B allele has been disrupted by homologous recombination as a step to generate mice that do not express the enzyme.

View original record on NIH RePORTER →